National Cancer Institute; Notice of Closed Meetings, 9248 [2014-03397]
Download as PDF
<![CDATA[
9248
Federal Register / Vol. 79, No. 32 / Tuesday, February 18, 2014 / Notices
the Board meeting. The Subcommittee
meeting will now start at 06:30 p.m. on
February 26, 2014, and end at 08:00
p.m., and the Board meeting will now
start at 8:30 a.m. on February 27, 2014.
The meeting is partially closed to the
public.
Dated: February 11, 2014.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2014–03407 Filed 2–14–14; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of
Closed Meetings
tkelley on DSK3SPTVN1PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Cancer
Institute Special Emphasis Panel; Training
and Career Development Application
Review.
Date: April 16, 2014.
Time: 1:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute Shady
Grove, 9609 Medical Center Drive, Room
7W110, Rockville, MD 20850 (Telephone
Conference Call).
Contact Person: Robert Bird, Ph.D.,
Resources and Training Review Branch,
Division of Extramural Activities, National
Cancer Institute, NIH, 9609 Medical Center
Drive, Room 7W110, Bethesda, MD 20892–
8328, 240–276–6344 birdr@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; NCORP
Minority Community Sites Review.
Date: April 22–23, 2014.
Time: 5:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Marriott Courtyard Gaithersburg,
Washingtonian Center, 204 Boardwalk Place,
Gaithersburg, MD 20878.
Contact Person: Michael B. Small, Ph.D.,
Chief, Program and Review Extramural Staff
Training Office, Division of Extramural
Activities, National Cancer Institute, NIH,
VerDate Mar<15>2010
20:58 Feb 14, 2014
Jkt 232001
9609 Medical Center Drive, Room 7W412,
Bethesda, MD 20892–9750, 240–276–6438
smallm@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; NCORP
Research Base.
Date: April 29–30, 2014.
Time: 3:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute Shady
Grove, 9609 Medical Center Drive, Room
2W910/912, Rockville, MD 20850.
Contact Person: Shamala K. Srinivas,
Ph.D., Scientific Review Officer, Office of
Referral, Review, and Program Coordination,
Division of Extramural Activities, National
Cancer Institute, NIH, 9609 Medical Center
Drive, Room 7W530, Bethesda, MD 20892–
9750, 240–276–6442, shamala@mail.nih.gov.
Information is also available on the
Institute’s Center’s home page: https://
deainfo.nci.nih.gov/advisory/sep/sep.htm,
where a roster and any additional
information for the meeting will be posted
when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS).
Dated: February 12, 2014.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2014–03397 Filed 2–14–14; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Amended
Notice of Meeting
Notice is hereby given of a change in
the meeting of the National Cancer
Institute Special Emphasis Panel, March
20, 2014, 07:00 p.m. to March 21, 2014,
04:00 p.m., Courtyard Marriott
Washingtonian Center, 204 Boardwalk
Place, Gaithersburg, MD 20878 which
was published in the Federal Register
on February 07, 2014, 79FR7466.
The meeting notice is amended to
change the location and time to 9609
Medical Center Drive, Room 5E30,
Rockville, MD 20850, March 20, 2014,
10:00 a.m. to March 21, 2014, 3:30 p.m.
Additionally the meeting is being held
as a teleconference. The meeting is
closed to the public.
PO 00000
Frm 00092
Fmt 4703
Sfmt 4703
Dated: February 12, 2014.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2014–03399 Filed 2–14–14; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Prospective Grant of Exclusive
License: Pre-Clinical Evaluation and
Commercial Development of Human
Therapeutics for Liver Cancer and
Ovarian Cancer Within the Scope of
the Licensed Patent Rights
AGENCY:
National Institutes of Health,
HHS.
ACTION:
Notice.
This is notice, in accordance
with 35 U.S.C. 209 and 37 CFR part 404,
that the National Institutes of Health,
Department of Health and Human
Services, is contemplating the grant of
an exclusive evaluation option license
to practice the inventions covered under
the scope of the following patents and
patent applications:
• United States Patent No. 8,207,142
issued Jun 26, 2012 entitled ‘‘Inhibitor
of DNA Methylation’’ (HHS Ref. No. E–
081–2001/2–US–06);
• EP Patent No. 1418949 issued June
19, 2013, entitled ‘‘Inhibitor of DNA
Methylation’’ (HHS Ref. No. E–081–
2001/2–EP–02) and validated in Great
Britain, Germany and France;
• Australia Patent No. 2002322805
issued February 21, 2008 entitled
‘‘Inhibitor of DNA Methylation’’ (HHS
Ref. No. E–081–2001/2–AU–03);
• Australia Patent No. 2008200601
issued November 25, 2010 entitled
‘‘Inhibitor of DNA Methylation’’ (HHS
Ref. No. E–081–2001/2–AU–07);
• Canada Patent No. 2,454,147 issued
May 21, 2013 entitled ‘‘Inhibitor of DNA
Methylation’’ (HHS Ref. No. E–081–
2001/2–CA–04);
• Japan Patent Application No. 2003–
517229 filed July 30, 2002 entitled
‘‘Inhibitor of DNA Methylation’’ (HHS
Ref. No. E–081–2001/2–JP–05); and
• Japan Patent No. 5416660 issued
November 22, 2013 entitled ‘‘Inhibitor
of DNA Methylation’’ (HHS Ref. No. E–
081–2001/2–JP–08)
to Metheor Therapeutics, Corporation
(‘‘METHEOR’’) a U.S. based company
located in Shoreline, WA, USA. The
patent rights in this invention have been
assigned to the government of the
United States of America.
The prospective exclusive evaluation
option license territory may be
SUMMARY:
E:\FR\FM\18FEN1.SGM
18FEN1
]]>Agencies
[Federal Register Volume 79, Number 32 (Tuesday, February 18, 2014)]
[Notices]
[Page 9248]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-03397]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Cancer Institute Special Emphasis
Panel; Training and Career Development Application Review.
Date: April 16, 2014.
Time: 1:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute Shady Grove, 9609 Medical
Center Drive, Room 7W110, Rockville, MD 20850 (Telephone Conference
Call).
Contact Person: Robert Bird, Ph.D., Resources and Training
Review Branch, Division of Extramural Activities, National Cancer
Institute, NIH, 9609 Medical Center Drive, Room 7W110, Bethesda, MD
20892-8328, 240-276-6344 birdr@mail.nih.gov.
Name of Committee: National Cancer Institute Special Emphasis
Panel; NCORP Minority Community Sites Review.
Date: April 22-23, 2014.
Time: 5:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Marriott Courtyard Gaithersburg, Washingtonian Center,
204 Boardwalk Place, Gaithersburg, MD 20878.
Contact Person: Michael B. Small, Ph.D., Chief, Program and
Review Extramural Staff Training Office, Division of Extramural
Activities, National Cancer Institute, NIH, 9609 Medical Center
Drive, Room 7W412, Bethesda, MD 20892-9750, 240-276-6438
smallm@mail.nih.gov.
Name of Committee: National Cancer Institute Special Emphasis
Panel; NCORP Research Base.
Date: April 29-30, 2014.
Time: 3:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute Shady Grove, 9609 Medical
Center Drive, Room 2W910/912, Rockville, MD 20850.
Contact Person: Shamala K. Srinivas, Ph.D., Scientific Review
Officer, Office of Referral, Review, and Program Coordination,
Division of Extramural Activities, National Cancer Institute, NIH,
9609 Medical Center Drive, Room 7W530, Bethesda, MD 20892-9750, 240-
276-6442, shamala@mail.nih.gov.
Information is also available on the Institute's Center's home
page: https://deainfo.nci.nih.gov/advisory/sep/sep.htm, where a
roster and any additional information for the meeting will be posted
when available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.392,
Cancer Construction; 93.393, Cancer Cause and Prevention Research;
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer
Control, National Institutes of Health, HHS).
Dated: February 12, 2014.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2014-03397 Filed 2-14-14; 8:45 am]
BILLING CODE 4140-01-P
